Cover Image
市場調查報告書

Aureogen Biosciences, Inc.:產品平台分析

Aureogen Biosciences, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321979
出版日期 內容資訊 英文 17 Pages
訂單完成後即時交付
價格
Back to Top
Aureogen Biosciences, Inc.:產品平台分析 Aureogen Biosciences, Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 17 Pages
簡介

AureoGen Biosciences, Inc. 是開發為修正環狀胜肽系化合物用化學及分子生物學手法的生物科技企業。該公司產品有青霉素(Penicillin)、萬古霉素(Vancomycin)、達托黴素(Daptomycin),棘白菌素(Echinocandin),環孢素(Cyclosporine)、博萊黴素(Bleomycin)等,用於抗生素,抗真菌藥物,免疫抑製藥,癌症治療藥。

本報告提供Aureogen Biosciences, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Aureogen Biosciences, Inc.的基本資料

Aureogen Biosciences, Inc.概要

  • 主要資訊
  • 企業資料

Aureogen Biosciences, Inc.:R&D概要

  • 主要的治療範圍

Aureogen Biosciences, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Aureogen Biosciences, Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Aureogen Biosciences, Inc.:藥物簡介

  • AUGC-15
  • BMY-28117
  • AUGC-10

Aureogen Biosciences, Inc.:開發平台分析

  • 各分子類型

Aureogen Biosciences, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06986CDB

Summary

Global Markets Direct's, 'Aureogen Biosciences, Inc. - Product Pipeline Review - 2015', provides an overview of the Aureogen Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aureogen Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aureogen Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aureogen Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aureogen Biosciences, Inc.'s pipeline products

Reasons to buy

  • Evaluate Aureogen Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aureogen Biosciences, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aureogen Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aureogen Biosciences, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aureogen Biosciences, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aureogen Biosciences, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aureogen Biosciences, Inc. Snapshot
    • Aureogen Biosciences, Inc. Overview
    • Key Information
    • Key Facts
  • Aureogen Biosciences, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Aureogen Biosciences, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Aureogen Biosciences, Inc. - Pipeline Products Glance
    • Aureogen Biosciences, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Aureogen Biosciences, Inc. - Drug Profiles
    • AUGC-15
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BMY-28117
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AUGC-10
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aureogen Biosciences, Inc. - Pipeline Analysis
  • Aureogen Biosciences, Inc. - Pipeline Products by Molecule Type
  • Aureogen Biosciences, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aureogen Biosciences, Inc., Key Information
  • Aureogen Biosciences, Inc., Key Facts
  • Aureogen Biosciences, Inc. - Pipeline by Indication, 2015
  • Aureogen Biosciences, Inc. - Pipeline by Stage of Development, 2015
  • Aureogen Biosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Aureogen Biosciences, Inc. - Preclinical, 2015
  • Aureogen Biosciences, Inc. - Discovery, 2015
  • Aureogen Biosciences, Inc. - Pipeline by Molecule Type, 2015

List of Figures

  • Aureogen Biosciences, Inc. - Pipeline by Top 10 Indication, 2015
  • Aureogen Biosciences, Inc. - Pipeline by Stage of Development, 2015
  • Aureogen Biosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Aureogen Biosciences, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top